Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Ambry Genetics Launches Public Genetic Database, Takes Stand on Data Sharing
From - Diagnostic Testing & Emerging Technologies
Ambry Genetics (Aliso Viejo, Calif.) took a stance in the debate over sharing of genetic data this week. The genetic testing firm launched…
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From - Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
Consensus Needed on Recontacting Patients With Updated Genetic Results
From - Diagnostic Testing & Emerging Technologies
The majority of U.K. clinical genetics services report that they recontact patients or family members about new findings relevant to…
Genomic Testing Shows Promise for Metastatic Prostate Cancer
From - Diagnostic Testing & Emerging Technologies
On the heels of last week's White House Precision Medicine Summit, new research findings suggest that a personalized approach can…
Portable Sequencer Provides Real-Time Outbreak Surveillance
From - Diagnostic Testing & Emerging Technologies
Real-time genomic surveillance is possible in resource-limited settings to monitor infectious disease outbreaks, according to…
PSA Testing Patterns Vary By Medical Specialty
From - Diagnostic Testing & Emerging Technologies
Prostate specific antigen (PSA) testing varies significantly by physician specialty, according to a research letter published online Feb. 8 in…
New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis
From - Diagnostic Testing & Emerging Technologies
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…
2015 Had Promising Signs Amid Tough Fundraising Climate for Dx Cos
...
Already a member? Log in here
Testing Trends to Watch for in 2016
...
Already a member? Log in here
PCT Effective to ID Invasive Bacterial Infection in Febrile Infants
...
Already a member? Log in here